Victoria, Canada–(ENEWSPF)–February 16, 2017. Patients with legal access to medical cannabis reduce their use of opioids, benzodiazepines, and other prescription drugs, according to data published online ahead of print in The International Journal of Drug Policy. Researchers at the University of Victoria and the University of British Columbia assessed the[Read More…]
Health and Fitness
Bi-Partisan Congressional Cannabis Caucus Holds Press Conference, Feb. 16, 2017 (Video)
U.S. Rep. Earl Blumenauer (D-Ore.) has championed efforts to reform marijuana laws since 1973 Washington, DC—(ENEWSPF)—February 16, 2017. At the U.S. Capitol today, Representatives Dana Rohrabacher (CA-48), Earl Blumenauer (OR-03), Don Young (AK-At Large), and Jared Polis (CO-02) launched the Congressional Cannabis Caucus – the first of its kind. Watch the[Read More…]
High-Risk Pools Are Not a Feasible Alternative to the Affordable Care Act’s Pre-Existing Conditions Protection
A young patient who uses a special program funded by the Affordable Care Act embraces his medical specialist, on December 16, 2016. AP/Charles Krupa Washington, D.C. —(ENEWSPF)–February 16, 2017. As the Center for Medicare and Medicaid Services under the Trump administration rolls out rules designed solely to benefit the insurance[Read More…]
Reps. DeFazio, Courtney Introduce Legislation Supporting a Public Health Insurance Option
Public Option would Lower Costs, Increase Competition among Private Insurance Monopolies Washington, DC–(ENEWSPF)–February 16, 2017. Reps. Peter DeFazio (OR-04) and Joe Courtney (CT-02) yeesterday introduced a resolution supporting the inclusion of a public health insurance option in the American health insurance market, H. Res. 130. “As President Trump and Congressional[Read More…]
FDA Approves New Psoriasis Drug
Silver Spring, Maryland—(ENEWSPF)—February 15, 2017. The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken[Read More…]
Package of Overdose Prevention Bills Clear the New Mexico State Senate
More New Mexicans Die from an Unintentional Drug Overdose than in a Motor Vehicle Crash, Including Alcohol Involved Motor Vehicle Crashes Santa Fe –(ENEWSPF)–February 13, 2017. A package of overdose prevention bills (Senate Bill 47 and Senate Bill 16) passed the New Mexico State Senate with overwhelming support from both[Read More…]
American Academy of Pediatrics Offers Customizable Allergy and Anaphylaxis Emergency Plan to Guide Effective Management
Elk Grove Village, IL–(ENEWSPF)–February 13, 2017. Reaffirming the importance of epinephrine in first-aid treatment for anaphylaxis—and written plans for when and how to use it–the American Academy of Pediatrics (AAP) released a new, written action plan to help patients, families, schools and communities best respond to life-threatening allergic reactions. The[Read More…]
Epilepsy Drug Discovered in Fish Model Shows Promise in Small Pediatric Clinical Trial
NIH-funded research suggests zebrafish models may be efficient resource for identifying drugs for clinical use. Bethesda, Maryland–(ENEWSPF)–February 13, 2017. “Bench-to-bedside” describes research that has progressed from basic science in animal models that has led to therapies used in patients. Now, a study in the journal Brain describes what could be[Read More…]
Women’s Fertility May Decrease with Physically Demanding or Shift Work
Boston, MA –(ENEWSPF)–February 9, 2017. Women who lift heavy loads at work may experience decreased fertility, and the effect appears stronger among overweight or obese women and older women, according to a new study from Harvard T.H. Chan School of Public Health. Working non-daytime work schedules may also decrease[Read More…]
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Silver Spring, Maryland–(ENEWSPF)–February 9, 2017. The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by[Read More…]
